Takeda Pharmaceutical Company Limited Stock
Stocks
4502
JP3463000004
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,359.00 JPY | +1.61% |
|
+5.35% | +10.84% |
| 07-02 | Asian Equities Traded in the US as American Depositary Receipts Surge in Thursday Trading | MT |
| 07-02 | Takeda, Insilico Sign AI-Driven Drug Discovery Pact | MT |
| Market Cap | 8,467B 52.43B 45.86B 42.15B 39.29B 74.47B 4,994B 75.62B 502B 197B 2,458B 197B 193B | P/E 2027 * |
43.6x | P/E 2028 * | 27.9x |
|---|---|---|---|---|---|
| Enterprise Value | 12,352B 76.5B 66.91B 61.5B 57.33B 109B 7,286B 110B 732B 287B 3,587B 287B 281B | EV / Sales 2027 * |
2.67x | EV / Sales 2028 * | 2.6x |
| Free-Float |
99.25% | Yield 2027 * |
3.81% | Yield 2028 * | 3.89% |
Last Transcript: Takeda Pharmaceutical Company Limited
| 1 day | +1.61% | ||
| 1 week | +5.35% | ||
| Current month | +3.96% | ||
| 1 month | +10.49% | ||
| 3 months | -7.64% | ||
| 6 months | +10.84% | ||
| Current year | +10.84% |
| 1 week | 5,100 |  | 5,515 |
| 1 month | 4,896 | | 5,515 |
| Current year | 4,710 | | 6,033 |
| 1 year | 4,102 | | 6,033 |
| 3 years | 3,852 | | 6,033 |
| 5 years | 2,993 | | 6,033 |
| 10 years | 2,894.5 | | 6,693 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 24/06/2026 | |
Mikuno Furuta
DFI | Director of Finance/CFO | 48 | 01/04/2024 |
Gabriele Ricci
CTO | Chief Tech/Sci/R&D Officer | 47 | 01/02/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Andrew Plump
BRD | Director/Board Member | 60 | 01/06/2015 |
Steven Gillis
BRD | Director/Board Member | 73 | 01/01/2019 |
Mikuno Furuta
BRD | Director/Board Member | 48 | 01/06/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 04-27 | Free | Executive/Senior Manager | 64,988 | 0.0041% | ||
| 04-27 | Free | Chief Executive Officer | 323,248 | 0.0203% | ||
| 04-27 | Free | Executive/Senior Manager | 72,124 | 0.0045% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.61% | +5.35% | +20.70% | +18.61% | 52.5B | |
| +1.86% | +0.48% | +55.50% | +163.08% | 1,082B | |
| +3.57% | +3.29% | +68.60% | +61.03% | 633B | |
| +3.99% | +3.05% | +37.93% | +93.37% | 461B | |
| -0.26% | +1.37% | +31.00% | +23.97% | 338B | |
| -0.56% | +0.96% | +39.86% | +36.64% | 299B | |
| -0.08% | +1.30% | +30.37% | +44.02% | 291B | |
| -1.54% | +2.81% | -27.56% | -39.45% | 222B | |
| +3.55% | +4.41% | +25.45% | +66.28% | 202B | |
| +4.21% | +2.65% | +17.47% | +71.11% | 163B | |
| Average | +1.64% | +4.54% | +29.93% | +53.87% | 374.49B | |
| Weighted average by Cap. | +1.86% | +5.43% | +41.45% | +82.07% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 4,630B 28.68B 25.08B 23.05B 21.49B 40.73B 2,731B 41.36B 275B 107B 1,344B 108B 105B | 4,701B 29.11B 25.46B 23.4B 21.82B 41.35B 2,773B 41.99B 279B 109B 1,365B 109B 107B |
| Net income | 184B 1.14B 996M 916M 853M 1.62B 108B 1.64B 10.9B 4.27B 53.4B 4.28B 4.19B | 309B 1.92B 1.68B 1.54B 1.44B 2.72B 182B 2.76B 18.34B 7.18B 89.81B 7.2B 7.04B |
| Net Debt | 3,886B 24.06B 21.05B 19.35B 18.03B 34.18B 2,292B 34.71B 230B 90.18B 1,128B 90.4B 88.46B | 3,750B 23.23B 20.32B 18.67B 17.41B 32.99B 2,212B 33.5B 222B 87.05B 1,089B 87.26B 85.38B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/07/26 | ¥5,359.00 | +1.61% | 4,074,200 |
| 02/07/26 | ¥5,274.00 | +2.41% | 3,538,100 |
| 01/07/26 | ¥5,150.00 | -0.10% | 4,177,200 |
| 30/06/26 | ¥5,155.00 | -0.41% | 4,329,100 |
| 29/06/26 | ¥5,176.00 | +1.75% | 7,388,100 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4502 Stock
Select your edition
All financial news and data tailored to specific country editions
